Outcomes 2019 - Baylor Scott & White Heart and Vascular Hospital BSWHHVH_646_2019 Outcomes JOOMAG MOD | Page 27

Chronic total occlusion stenting
Baylor Scott & White Heart and Vascular Hospital
– Dallas is a regional and national referral center
for high-risk patients seeking treatment for
totally occluded arteries with chronic total
occlusion (CTO) stenting. An option to bypass
surgery, the hospital is among a handful of
medical facilities in Texas offering this service
to address coronary obstructions. In addition
to being one of the highest volume CTO
cardiac centers in the nation, the hospital is also
dedicated to research and innovation.
Baylor Scott & White Heart and Vascular Hospital
– Dallas is participating in the CTO Progress
Registry, a national database of elite cardiac
centers nationwide that share data to identify
best practices and best outcomes. Patients
benefit from CTO-related studies including
various research trials to drive innovation.
The hospital’s participation in the registry
differentiates the program’s capabilities from
many others.
Chronic total occlusions
(FY19)
127
Ekosonic™ Endovascular System (EKOS)
In fiscal year 2019, interventional cardiologists on
the medical staff of Baylor Scott & White Heart
and Vascular Hospital – Dallas continued to use
the new EKOS technology to treat pulmonary
embolism and deep vein thrombosis. The
approach helps improve the efficiency of the
thrombolytic process and reduce the treatment
time and total lytic dose, thereby reducing the
associated bleeding risk and overall cost of
therapy. EKOS enables ultrasound facilitated,
Specialized interventional procedures
Angioplasty-related interventional procedures—
PCI, balloon angioplasty, coronary angioplasty,
coronary artery angioplasty, percutaneous
transluminal coronary angioplasty, and heart
artery dilatation—are foundational components
of the hospital’s interventional cardiology
program. Patients diagnosed with unprotected
left main disease (ULM) in fiscal year 2019
continued to be referred to the highly skilled and
experienced interventional cardiologists on the
hospital’s medical staff for advanced treatment.
Other specialized interventional services
available to patients at Baylor Scott & White
Heart and Vascular Hospital – Dallas include:
• Advanced generation of stents
• Atrial septal defect (ASD) and patent foramen
ovale (PFO) closure
• Balloon valve repair
• Cardiac assist devices – a variety of assist
devices are offered including the potential for
patient enrollment in device studies
• Carotid stenting – many of the recent
to-market stents were originally researched
on the Dallas campus
• Coronary angioplasty and stenting
• Coronary atherectomy
• Percutaneous coronary intervention (PCI)
of chronic total occlusions
• Impella – an assist device
• TandemHeart
• CardioMEMS™ heart failure system
• Peripheral angiography and angioplasty
• Peripheral atherectomy
• Unprotected left main disease intervention
• Extracorporeal membrane oxygenation (ECMO)
®
®
Baylor Scott & White Heart and Vascular
Hospital, together with Baylor University
Medical Center, achieved certification by The
Joint Commission for Chest Pain. The Gold Seal
was awarded by The Joint Commission after
a thorough review of performance for acute
myocardial infarction (AMI) and acute coronary
syndrome (ACS).
controlled and selective infusion of physician-
specified fluids, including thrombolytics,
into the vasculature for the treatment of
pulmonary embolism. The EKOS technology
is intended for the treatment of pulmonary
embolism patients with ≥50% clot burden in
one or both main pulmonary arteries or lobar
pulmonary arteries, and evidence of right heart
dysfunction based on right heart pressures
(mean pulmonary artery pressure ≥25 mmHg) or
echocardiographic evaluation.
The Joint Commission chest pain
certification
27